Consult the medical resource doctors trust

UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Hypertensive emergencies: Malignant hypertension and hypertensive encephalopathy

DEFINITIONS

Hypertensive emergencies are acute, life-threatening, and usually associated with marked increases in blood pressure (BP), generally ≥180/120 mmHg (table 1) [1-3]. There are two major clinical syndromes induced by the severe hypertension:

  • Malignant hypertension is marked hypertension with retinal hemorrhages, exudates, or papilledema. There may also be renal involvement, called malignant nephrosclerosis. Although papilledema had been thought to represent a more severe lesion, it does not appear to connote a worse prognosis than hemorrhages and exudates alone (so-called accelerated hypertension) [4]. Thus, treatment is the same whether or not papilledema is present.
  • Hypertensive encephalopathy refers to the presence of signs of cerebral edema caused by breakthrough hyperperfusion from severe and sudden rises in blood pressure.

MECHANISMS OF VASCULAR INJURY

With mild to moderate elevations in blood pressure, the initial response is arterial and arteriolar vasoconstriction. This autoregulatory process both maintains tissue perfusion at a relatively constant level and prevents the increase in pressure from being transmitted to the smaller, more distal vessels [5].

With increasingly severe hypertension, however, autoregulation eventually fails (graph 1) [5]. The ensuing rise in pressure in the arterioles and capillaries leads to damage to the vascular wall. Disruption of the vascular endothelium then allows plasma constituents (including fibrinoid material) to enter the vascular wall, thereby narrowing or obliterating the vascular lumen. Within the brain, the breakthrough vasodilation from failure of autoregulation leads to the development of cerebral edema and the clinical picture of hypertensive encephalopathy [5].

The level at which fibrinoid necrosis occurs is dependent upon the baseline BP. Patients with chronic hypertension have arteriolar hypertrophy that minimizes the transmission of pressure to the capillary circulation. As a result, malignant hypertension is usually associated with a diastolic pressure above 120 mmHg. In comparison, hypertensive encephalopathy can be seen at diastolic pressures as low as 100 mmHg in previously normotensive patients with acute hypertension due to preeclampsia or acute glomerulonephritis; patients in whom autoregulation is impaired also may develop hypertensive injury at relatively mild degrees of hypertension [5].

To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Kaplan, NM. Management of hypertensive emergencies. Lancet 1994; 344:1335.
  2. Chobanian, AV, Bakris, GL, Black, HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560.
  3. Rosei, EA, Salvetti, M, Farsang, C. European Society of Hypertension Scientific Newsletter: treatment of hypertensive urgencies and emergencies. J Hypertens 2006; 24:2482.
  4. Ahmed, ME, Walker, JM, Beevers, DG, Beevers, M. Lack of difference between malignant and accelerated hypertension. Br Med J 1986; 292:235.
  5. Strandgaard, S, Paulson, OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 1989; 2:486.
  6. Montgomery, HE, Kiernan, LA, Whitworth, CE, et al. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN)27. J Hypertens 1998; 16:635.
  7. Patel, R, Ansari, A, Grim, CE. Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients. Am J Cardiol 1990; 66:868.
  8. Davis, BA, Crook, JE, Vestal, RE, Oakes, JA. Prevalence of renovascular hypertension in patients with grade III or IV retinopathy. N Engl J Med 1979; 301:1273.
  9. Kaplan, NM. Hypertensive crises. In: Kaplan's Clinical Hypertension, 9th ed, Neal, W (Ed), Lippincott, Williams and Wilkins, Baltimore 2006. p.311.
  10. Vaughan, CJ, Delanty, N. Hypertensive emergencies. Lancet 2000; 356:411.
  11. Phillips, SJ, Whisnant, JP, on behalf of the National High Blood Pressure Education Program. Hypertension and the brain. Arch Intern Med 1992; 152:938.
  12. Hinchey, J, Chaves, C, Appignani, B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.
  13. Kitaguchi, H, Tomimoto, H, Miki, Y, et al. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 2005; 47:652.
  14. Meylaerts, L, Ooms, V, Lyra, S, et al. Hypertensive brain stem encephalopathy in a patient with chronic renal failure. Clin Nephrol 2006; 65:138.
  15. Neutel, JM, Smith, DH, Wallin, D, et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens 1994; 7:623.
  16. Angeli, P, Chiesa, M, Caregaro, L, et al. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med 1991; 151:678.
  17. Grossman, E, Messerli, FH, Grodzicki, T, et al. Should a moratorium be placed on sublingual nifedipine capsules for hypertensive emergencies or psuedoemergencies? JAMA 1996; 276:1328.
  18. Ledingham, JG, Rajagopalan, B. Cerebral complications in the treatment of accelerated hypertension. Q J Med 1979; 48:25.
  19. Haas, DC, Streeten, DHP, Kim, RC, et al. Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension. Am J Med 1983; 75:1071.
  20. Woods, JW, Blythe, WB. Management of malignant hypertension complicated by renal insufficiency. N Engl J Med 1967; 277:57.
  21. Lip, GY, Beevers, M, Beevers, DG. Does renal function improve after diagnosis of malignant phase hypertension? J Hypertens 1997; 15:1309.
  22. van den, Born BJ, Honnebier, UP, Koopmans, RP, van Montfrans, GA. Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension 2005; 45:246.
white circle LOG IN
white circle DEMO